Drugs Under Development
- Elvitegravir (GS 9137 or JTK-303), licensed by Gilead Sciences from Japan Tobacco, is currently undergoing Phase 3 clinical trials. GS 9137 is a low-molecular-weight, highly selective integrase inhibitor that shares the core structure of quinolone antibiotics.
- MK-2048, a second generation integrase inhibitor, that appears to have a duration of action up to 4 times longer than raltegravir.
Read more about this topic: Integrase Inhibitor
Famous quotes containing the words drugs and/or development:
“To possess your soul in patience, with all the skin and some of the flesh burnt off your face and hands, is a job for a boy compared with the pains of a man who has lived pretty long in the exhilarating world that drugs or strong waters seem to create and is trying to live now in the first bald desolation created by knocking them off.”
—C.E. (Charles Edward)
“Information about child development enhances parents’ capacity to respond appropriately to their children. Informed parents are better equipped to problem-solve, more confident of their decisions, and more likely to respond sensitively to their children’s developmental needs.”
—L. P. Wandersman (20th century)